National Resilience, Inc., a technology-focused biomanufacturing company dedicated to broadening access to complex medicines, and Lifera, a biopharmaceutical company wholly owned by the Public Investment Fund (PIF), have entered into a non-binding term sheet for the development of biopharma manufacturing capacity in Riyadh, Saudi Arabia. Through this strategic joint venture and working with Lifera, Resilience would provide expertise for the design, construction, and commission of a cGMP state...